475 related articles for article (PubMed ID: 38713256)
41. The role of tumor-associated macrophages in osteosarcoma progression - therapeutic implications.
Huang Q; Liang X; Ren T; Huang Y; Zhang H; Yu Y; Chen C; Wang W; Niu J; Lou J; Guo W
Cell Oncol (Dordr); 2021 Jun; 44(3):525-539. PubMed ID: 33788151
[TBL] [Abstract][Full Text] [Related]
42. Tumor-associated macrophages: an accomplice in solid tumor progression.
Chen Y; Song Y; Du W; Gong L; Chang H; Zou Z
J Biomed Sci; 2019 Oct; 26(1):78. PubMed ID: 31629410
[TBL] [Abstract][Full Text] [Related]
43. The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression.
Wang H; Yung MMH; Ngan HYS; Chan KKL; Chan DW
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207286
[TBL] [Abstract][Full Text] [Related]
44. Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities.
Wang G; Zhong K; Wang Z; Zhang Z; Tang X; Tong A; Zhou L
Front Immunol; 2022; 13():964898. PubMed ID: 35967394
[TBL] [Abstract][Full Text] [Related]
45. Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.
La Fleur L; Botling J; He F; Pelicano C; Zhou C; He C; Palano G; Mezheyeuski A; Micke P; Ravetch JV; Karlsson MCI; Sarhan D
Cancer Res; 2021 Feb; 81(4):956-967. PubMed ID: 33293426
[TBL] [Abstract][Full Text] [Related]
46. Macrophages in tumor: An inflammatory perspective.
Goswami KK; Bose A; Baral R
Clin Immunol; 2021 Nov; 232():108875. PubMed ID: 34740843
[TBL] [Abstract][Full Text] [Related]
47. Tumor-Associated Senescent Macrophages, Their Markers, and Their Role in Tumor Microenvironment.
Pukhalskaia TV; Yurakova TR; Bogdanova DA; Demidov ON
Biochemistry (Mosc); 2024 May; 89(5):839-852. PubMed ID: 38880645
[TBL] [Abstract][Full Text] [Related]
48. Manipulation of the tumor immuno-microenvironment via TAM-targeted expression of transcription factors.
Musick M; Yu X
Immunol Res; 2022 Aug; 70(4):432-440. PubMed ID: 35486115
[TBL] [Abstract][Full Text] [Related]
49. Targeting tumor-associated macrophages for cancer immunotherapy.
Shu Y; Cheng P
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188434. PubMed ID: 32956767
[TBL] [Abstract][Full Text] [Related]
50. Nanomaterials in modulating tumor-associated macrophages and enhancing immunotherapy.
Liang C; Zhang Y; Wang S; Jiao W; Guo J; Zhang N; Liu X
J Mater Chem B; 2024 May; 12(20):4809-4823. PubMed ID: 38695349
[TBL] [Abstract][Full Text] [Related]
51. CD133-containing microvesicles promote cancer progression by inducing M2-like tumor-associated macrophage polarization in the tumor microenvironment of colorectal cancer.
Kim SY; Park S; Kim S; Ko J
Carcinogenesis; 2024 May; 45(5):300-310. PubMed ID: 38085813
[TBL] [Abstract][Full Text] [Related]
52. [Research progress on tumor-associated macrophages in colorectal cancer].
Huang S; Li F; Jin D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Oct; 39(10):940-945. PubMed ID: 37882718
[TBL] [Abstract][Full Text] [Related]
53. Macrophage barrier in the tumor microenvironment and potential clinical applications.
Ji S; Shi Y; Yin B
Cell Commun Signal; 2024 Jan; 22(1):74. PubMed ID: 38279145
[TBL] [Abstract][Full Text] [Related]
54. Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies.
Kumari N; Choi SH
J Exp Clin Cancer Res; 2022 Feb; 41(1):68. PubMed ID: 35183252
[TBL] [Abstract][Full Text] [Related]
55. Targeting tumor-associated macrophages to synergize tumor immunotherapy.
Xiang X; Wang J; Lu D; Xu X
Signal Transduct Target Ther; 2021 Feb; 6(1):75. PubMed ID: 33619259
[TBL] [Abstract][Full Text] [Related]
56. Targeting tumor-associated macrophages to reverse antitumor drug resistance.
Li S; Sheng J; Zhang D; Qin H
Aging (Albany NY); 2024 May; 16(11):10165-10196. PubMed ID: 38787372
[TBL] [Abstract][Full Text] [Related]
57. Therapeutic Approaches Targeting Proteins in Tumor-Associated Macrophages and Their Applications in Cancers.
Wu D; Liu X; Mu J; Yang J; Wu F; Zhou H
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327584
[TBL] [Abstract][Full Text] [Related]
58. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
Gao J; Liang Y; Wang L
Front Immunol; 2022; 13():888713. PubMed ID: 35844605
[TBL] [Abstract][Full Text] [Related]
59. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
60. Tumor-associated Macrophages (TAMs) in Cancer Resistance; Modulation by Natural Products.
Lafta HA; AbdulHussein AH; Al-Shalah SAJ; Alnassar YS; Mohammed NM; Akram SM; Qasim MT; Najafi M
Curr Top Med Chem; 2023; 23(12):1104-1122. PubMed ID: 36722486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
